As the ratio of Gr1+/Gr1− monocytes is significantly decreased in a context of AD, less CX3CR1lowLy6-ChighGr1+CCR2+ monocytes are available to clear Aβ in the bloodstream but also to be recruited into brain to remove brain Aβ. This evidence concerns the gene CCR2 and Alzheimer disease.